JRCT ID: jRCT2080223958
Registered date:25/06/2018
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 21/06/2017 |
Target sample size | 240 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Valbenazine Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy confirmatory |
---|---|
Secondary Outcome | safety efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 85age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03176771,JapicCTI-184016 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
cti-inq-ml@ml.mt-pharma.co.jp | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
cti-inq-ml@ml.mt-pharma.co.jp | |
Affiliation |